Introduction Renal cell carcinoma (RCC) accounts for 2.2% of all cancer cases and 1.8% of global cancer incidence, with an increasing trend in recent years ( 1 ).
← all excerpts
Prognostic significance of systemic immunoinflammatory biomarkers in patients with clear cell renal cell carcinoma: a retrospective multicenter analysis.
1
—
—